Fasting-mimicking diet and hormone therapy induce breast cancer regression (vol 583, pg 620, 2020)

被引：9
|
作者：
Caffa, Irene
Spagnolo, Vanessa
Vernieri, Claudio
Valdemarin, Francesca
Becherini, Pamela
Wei, Min
Brandhorst, Sebastian
Zucal, Chiara
Driehuis, Else
Ferrando, Lorenzo
Piacente, Francesco
Tagliafico, Alberto
Cilli, Michele
Mastracci, Luca
Vellone, Valerio G.
Piazza, Silvano
Cremonini, Anna Laura
Gradaschi, Raffaella
Mantero, Carolina
Passalacqua, Mario
Ballestrero, Alberto
Zoppoli, Gabriele
Cea, Michele
Arrighi, Annalisa
Odetti, Patrizio
Monacelli, Fiammetta
Salvadori, Giulia
Cortellino, Salvatore
Clevers, Hans
De Braud, Filippo
Sukkar, Samir G.
Provenzani, Alessandro
Longo, Valter D.
Nencioni, Alessio
机构：
[1] IRCCS Ospedale Policlinico San Martino,Department of Oncology and Hemato
[2] University of Milan,Oncology
[3] IFOM,Medical Oncology and Hematology Department
[4] FIRC Institute of Molecular Oncology,Department of Internal Medicine and Medical Specialties
[5] Fondazione IRCCS Istituto Nazionale dei Tumori,Longevity Institute, Leonard Davis School of Gerontology and Department of Biological Sciences
[6] University of Genoa,Department of Cellular, Computational, and Integrative Biology (CIBIO)
[7] University of Southern California,Oncode Institute and Hubrecht Institute
[8] University of Trento,Department of Health Sciences
[9] Royal Netherlands Academy of Arts and Sciences,Department of Integrated Surgical and Diagnostic Sciences
[10] University Medical Center Utrecht,Department of Experimental Medicine
[11] University of Genoa,undefined
[12] University of Genoa,undefined
[13] University of Genoa,undefined
[14] Princess Maxima Center for Pediatric Oncology,undefined
来源：
NATURE | 2020年 / 588卷 / 7839期
关键词：
D O I：
10.1038/s41586-020-2957-6
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
引用
收藏
页码：E33 / E33
页数：1
相关论文
共 50 条
  • [31] Ribociclib in Combination with endocrine Therapy improves Survival of pre-/perimenopausal Breast Cancer Patients (vol 196, pg 286, 2020)
    Krug, David
    Fabian, Alexander
    Dunst, Juergen
    STRAHLENTHERAPIE UND ONKOLOGIE, 2021, 197 (07) : 650 - 650
  • [32] A Phase II Study of Abemaciclib in Patients with Brain Metastases Secondary to Hormone Receptor-positive Breast Cancer (vol 26, pg 5310, 2020)
    Tolaney, Sara M.
    Sahebjam, Solmaz
    Le Rhun, Emilie
    Bachelot, Thomas
    Kabos, Peter
    Awada, Ahmad
    Yardley, Denise
    Chan, Arlene
    Conte, Pierfranco
    Dieras, Veronique
    Lin, Nancy U.
    Bear, Melissa
    Chapman, Sonya C.
    Yang, Zhengyu
    Chen, Yanyun
    Anders, Carey K.
    CLINICAL CANCER RESEARCH, 2021, 27 (05) : 1582 - 1582
  • [33] The impact of menstruation persistence or recovery after chemotherapy on survival in young patients with hormone receptor negative breast cancer (vol 52, pg 102, 2020)
    van Barele, Mark
    Heemskerk-Gerritsen, Bernadette A. M.
    van Doorn, Helena C.
    Schmidt, Marjanka K.
    Hooning, Maartje J.
    Jager, Agnes
    BREAST, 2020, 53 : 221 - 222
  • [34] Endometrial cancer and menopausal hormone therapy in the National Institutes of Health-AARP diet and health study cohort (vol 109, pg 1303, 2007)
    Lacey, J., V
    Leitzmann, M. F.
    Chang, S-C
    Mouw, T.
    Hollenbeck, A. R.
    Schatzkin, A.
    Brinton, L. A.
    CANCER, 2007, 110 (04) : 937 - 937
  • [35] DIRECT2: A randomized phase III trial with a fasting mimicking diet program to improve chemotherapy in patients with hormone receptor positive, HER2-negative breast cancer-A Dutch Breast Cancer Research Group study (BOOG)
    de Gruil, Nadia
    Liefers, Gerrit-Jan
    Schagen, Sanne B.
    Meershoek, Elma
    Veen-Lievaart, Marielle E.
    Hinnen, Chris
    Putter, Hein
    Heijns, Joan B.
    Goosens, Anniek
    Tol, Jolien
    Baars, Arnold
    Veldhuis, Gerrit Jan
    Kessels, Lonneke W.
    van de Wouw, Agnes J.
    Vulink, Annelie J. E.
    Toonen, Frank A. J.
    Huinink, Daan Ten Bokkel
    van der Burg, Sjoerd H.
    Pijl, Hanno
    Kroep, Judith R.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [36] RE: Systemic or vaginal hormone therapy after early breast cancer: a Danish observational cohort study (vol 115, pg 220, 2023)
    Pederson, Holly J.
    Faubion, Stephanie S.
    Pruthi, Sandhya
    Goldfarb, Shari
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2023, 115 (04): : 483 - 483
  • [37] Risk of breast cancer after stopping menopausal hormone therapy in the E3N cohort (vol 145, pg 535, 2014)
    Fournier, Agnes
    Mesrine, Sylvie
    Dossus, Laure
    Boutron-Ruault, Marie-Christine
    Clavel-Chapelon, Francoise
    Chabbert-Buffet, Nathalie
    BREAST CANCER RESEARCH AND TREATMENT, 2014, 147 (01) : 225 - 225
  • [38] Breast density change as a predictive surrogate for response to adjuvant endocrine therapy in hormone receptor positive breast cancer (vol 14, pg R102, 2012)
    Kim, Jisun
    Han, Wonshik
    Moon, Hyeong-Gon
    Ahn, Soo K.
    Shin, Hee-Chul
    You, Jee-Man
    Han, Sae-Won
    Im, Seock-Ah
    Kim, Tae-You
    Koo, Hye R.
    Chang, Jung M.
    Cho, Nariya
    Moon, Woo K.
    Noh, Dong-Young
    BREAST CANCER RESEARCH, 2012, 14 (06)
  • [39] Adoption of hypofractionated radiation therapy for early breast cancer in private practice: the GenesisCare experience 2014-2106 (vol 64, pg 127, 2020)
    Neville, K.
    Dreosti, M.
    Blakey, D.
    Latham, M.
    Izard, M. A.
    Young, S.
    Graham, G.
    O'Brien, P.
    JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2020, 64 (04) : 598 - 598
  • [40] Hormone Replacement Therapy After Oophorectomy and Breast Cancer Risk Among BRCA1 Mutation Carriers (vol 4, pg 1059, 2018)
    Kotsopoulos, J.
    Gronwald, J.
    Karlan, B.
    JAMA ONCOLOGY, 2018, 4 (08) : 1139 - 1139
12345